VYOME HOLDINGS, INC. Amortization of Debt Issuance Costs
VYOME HOLDINGS, INC. (HIND) reported Amortization of Debt Issuance Costs of $494.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-04-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2023-04-17
- VYOME HOLDINGS, INC. amortization of debt issuance costs for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. amortization of debt issuance costs for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. amortization of debt issuance costs for the quarter ending 2021-06-30 was $33.00K.
- VYOME HOLDINGS, INC. amortization of debt issuance costs for the quarter ending 2021-03-31 was $461.00K.
- VYOME HOLDINGS, INC. amortization of debt issuance costs for fiscal 2021 was $494.00K, a 70.89% decline from fiscal 2020.
- VYOME HOLDINGS, INC. amortization of debt issuance costs for fiscal 2020 was $1.70M.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $0.00 derived: sum of 2 quarters · filed 2023-04-17 | $33.00K derived: sum of 3 quarters · filed 2023-04-17 | $494.00K 10-K · filed 2023-04-17 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $33.00K derived: sum of 2 quarters · filed 2022-11-14 | $494.00K 10-Q · filed 2022-11-14 | $799.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | $494.00K 10-Q · filed 2022-08-19 | $799.00K derived: sum of 3 quarters · filed 2022-08-19 | $1.44M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-03-31 | $461.00K 10-Q · filed 2022-05-23 | $766.00K derived: sum of 2 quarters · filed 2022-05-23 | $1.40M derived: sum of 3 quarters · filed 2022-05-23 | |
| 2020-12-31 | $305.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $941.00K derived: sum of 2 quarters · filed 2022-04-08 | $1.70M 10-K · filed 2022-04-08 | |
| 2020-09-30 | $636.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.39M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $756.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |